Clinical Trials Browser

Phase 1/2 × perifosine × Plasma cell × Clear all

NCT00401011 2018-02-23

Safety & Efficacy Study of Perifosine + Bortezomib +/- Dexamethasone for Multiple Myeloma Patients

Phase 1/2 Completed

Multiple Myeloma, Recurrence